Nicotinic Agonists Market
Nicotinic Agonists Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Nicotinic Agonists Market Size and Growth
The Nicotinic Agonists market is expanding due to rising demand in smoking cessation therapies and neurological disorders treatment. The global market size is projected to surpass $2 billion by 2025, driven by increasing research and development investments, along with the growing prevalence of conditions such as Alzheimer’s and Parkinson’s disease.
Companies Covered
(Covid 19 Impact Covered)
◍ FORUM Pharmaceuticals
◍ Karuna Pharmaceuticals
◍ Sumitomo Dainippon Pharma Co
◍ BMS
◍ Oyster Point Pharma
◍ Jiangsu Hansoh Pharmaceutical
◍ Dalian Meilun Biotech Co
The Nicotinic Agonists Market features companies like FORUM Pharmaceuticals, Karuna Pharmaceuticals, and Sumitomo Dainippon Pharma, focusing on neurological treatments. Their innovative therapies drive market growth, enhancing patient outcomes. Sales revenue for relevant firms includes:
- Karuna Pharmaceuticals: $25 million (2022)
- BMS: $46 billion (2022)
These figures reflect their market impact.
Request Sample Report
Market Segmentation
By Application
Alzheimer`s Disease (AD)
Schizophrenia
Others
Request Sample Report
By Product
Nicotine
Acetylcholine
Carbachol
Epibatidine
Others
Market Growth
Request Sample Report
$ X Billion USD
